Supplier Comparisons

Compare suppliers with clear criteria.

A dedicated hub for structured, transparent comparisons of research suppliers — focused on what can actually be verified rather than what marketing claims suggest.

Quick answer

What does a supplier comparison tell you?

It records the documentation and transparency we can verify. It does not certify product quality, safety, efficacy or suitability; unanswered questions remain visible.

  1. Check the criteriaUse the checklist
  2. Read the recordUnderstand a COA
  3. Compare contextSee the scorecard
Official supplier access

Visit a supplier website

Prefer direct access? These clearly marked affiliate links may earn Peptide Choice Guide a commission at no extra cost to you. They do not alter our evidence standards, review dates or editorial conclusions.

Start with the evidence, not the rating

A supplier review is most useful when you know what its documentation can establish — and where its limits remain. Use this short path before comparing any provider.

Read the COA

Match the lot, method, specification and reported result before treating a certificate as evidence.

How to read a COA →

Understand the method

See what HPLC and mass spectrometry may indicate — and what their labels do not prove.

Read the methods guide →

Check the source

Separate original records, supplier documents, secondary archives and unsupported claims.

Evaluate research sources →

Audit the COA library

Check coverage, lot matching, dates, methods and the gaps still visible across sampled records.

Audit a COA library →

Use the checklist

Note visible documentation and unanswered questions without converting a checklist into a product-quality score.

Open the checklist →

Published supplier reviews

Reviews are deliberately evidence-first and shown as dated snapshots. A supplier can have extensive documentation without automatically receiving a strong product-quality conclusion; each profile keeps its review date and unresolved evidence visible.

Checked Aug 26, 2026 · Documentation review

Ascension Peptides

Public COA library, lot-linked product records, laboratory identification and external document cross-checking. Final numerical score withheld pending broader COA review.

Read the full review →
Checked Aug 26, 2026 · Documentation review

Apollo Peptide Sciences

Public batch-linked documentation and sampled analytical reports with identity and purity information. Final score withheld pending systematic inspection of current reports.

Read the full review →
Checked Aug 26, 2026 · Documentation review

Limitless Life Nootropics

Now presented as Limitless Biotech. Strong public testing claims and substantial external testing history, but mixed independent results across compounds mean a final score is still withheld.

Read the full review →
Checked Aug 26, 2026 · Documentation review

American Peptides

Strong current COA infrastructure and substantial independently indexed testing coverage. Final score withheld until the underlying COA sample and policies are audited in full.

Read the full review →
Checked Aug 26, 2026 · Documentation review

Pinnacle Peptide Labs

Current batch-documentation claims, product-level COA links and a defined third-party testing policy. Final score withheld pending direct review of current COA PDFs.

Read the full review →
Checked Aug 26, 2026 · Documentation review

Swiss Chems

Public batch documentation and third-party testing claims, with materially mixed external results that require careful batch-level interpretation.

Read the full review →

Our supplier review framework

Every full supplier profile uses the same structure so readers can compare like with like.

1. Evidence & testing

COAs, batch numbers, laboratory identity, HPLC, mass spectrometry and other analytical documentation are assessed separately.

2. Traceability

We check whether documents can be connected to a specific product and batch rather than relying on generic certificates.

3. Company transparency

Company identity, policies, research-use positioning, support and other operational information are recorded when verifiable.

4. Evidence coverage

Missing information stays visible. A supplier cannot receive a strong score simply because key questions were never answered.

5. Editorial confidence

We distinguish verified evidence, supplier-provided information, secondary records and information we could not independently establish.

6. Commercial disclosure

Affiliate relationships are disclosed separately and do not increase a supplier's editorial score.

Read comparisons with context

Before relying on a rating or a supplier claim, use these resources to compare evidence status, review dates, lot traceability and unanswered questions.

How to Compare Peptide Supplier Reviews

Learn how to compare the evidence behind reviews without mistaking commercial signals for quality evidence.

Read the guide →

How to Read a Peptide COA

Understand the batch-level records that make a documentation claim more or less informative.

Read the COA guide →

Our editorial standards

See how we classify sources, score evidence coverage and disclose commercial relationships.

Read methodology →

Supplier Evidence Checklist

Record visible documentation, lot traceability and evidence gaps without turning a checklist into a quality score.

Use the checklist →

What a full review contains

SectionWhat we record
At a glanceLast checked date, evidence coverage and editorial confidence.
TestingCOA availability, batch specificity, laboratory identity and analytical methods.
TraceabilityWhether evidence can be tied to a specific lot or batch.
OperationsCompany identity, policies, research-use framing and support information.
ScorecardCriterion-level scores, evidence status and documented weights.
Evidence logSource, date checked and verification status for material claims.
Commercial relationshipClear affiliate disclosure where applicable.
Editorial note: Comparisons are informational. A score measures the evidence and transparency we can document; it is not a certification of product quality, safety, efficacy or suitability for human use. Missing evidence is not treated as positive evidence.